Isetan Mitsukoshi Holdings Ltd. (TYO:3099)

CTI BioPharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	835,371	781,778	936,280	565,951	368,924	296,440
Market Cap Growth	-16.50%	-16.50%	65.44%	53.41%	24.45%	25.65%
Enterprise Value	882,973	842,531	986,219	629,368	458,129	421,469
Last Close Price	2338.00	2139.50	2436.11	1424.65	919.62	731.76
PE Ratio	16.43	14.80	16.85	17.48	29.90	-
Forward PE	14.31	12.81	22.38	21.09	35.74	-
PS Ratio	1.50	1.41	1.75	1.16	0.88	0.36
PB Ratio	1.39	1.30	1.56	1.02	0.71	0.58
P/TBV Ratio	1.49	1.39	1.72	1.14	0.78	0.64
P/FCF Ratio	12.25	11.46	26.50	10.59	19.66	-
P/OCF Ratio	9.33	8.73	16.46	8.54	9.73	247.65
PEG Ratio	2.70	-	-	-	-	-
EV/Sales Ratio	1.59	1.52	1.84	1.29	1.10	0.52
EV/EBITDA Ratio	7.77	8.31	12.40	11.40	14.88	64.85
EV/EBIT Ratio	9.97	11.04	18.14	21.26	77.13	-
EV/FCF Ratio	12.95	12.36	27.92	11.78	24.42	-
Debt / Equity Ratio	0.14	0.14	0.20	0.30	0.34	0.41
Debt / EBITDA Ratio	0.85	0.85	1.52	2.99	5.69	32.14
Debt / FCF Ratio	1.27	1.27	3.42	3.09	9.34	-
Asset Turnover	0.46	0.46	0.44	0.41	0.35	0.67
Inventory Turnover	8.76	8.76	8.49	7.82	6.33	16.49
Quick Ratio	0.50	0.50	0.56	0.59	0.55	0.57
Current Ratio	0.67	0.67	0.73	0.71	0.69	0.75
Return on Equity (ROE)	8.77%	8.77%	9.62%	6.05%	2.36%	-7.95%
Return on Assets (ROA)	3.92%	3.92%	2.78%	1.55%	0.31%	-1.08%
Return on Capital (ROIC)	6.76%	6.76%	4.72%	2.62%	0.53%	-1.82%
Return on Capital Employed (ROCE)	9.20%	9.20%	6.50%	3.60%	0.70%	-
Earnings Yield	6.32%	6.76%	5.94%	5.72%	3.34%	-13.86%
FCF Yield	8.16%	8.72%	3.77%	9.44%	5.08%	-8.03%
Dividend Yield	2.57%	2.52%	1.40%	0.98%	1.09%	1.23%
Payout Ratio	32.41%	32.41%	13.70%	12.95%	33.97%	-
Buyback Yield / Dilution	2.80%	2.80%	0.18%	-0.04%	-0.51%	1.72%
Total Shareholder Return	5.37%	5.32%	1.58%	0.94%	0.58%	2.95%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.